Arab News , Tuesday, Dec 15, 2020 | Rabi Al Thani 30, 1442
Mona Obaid, medical director for KSA at Eli Lilly and Co
Dr. Mona Talib Obaid was recently appointed medical director for KSA at Eli Lilly and Co. She has become the first Saudi woman to hold a top leadership position in the Kingdom’s pharmaceutical sector.
Obaid received her MBBS from King Saud University in 2001. She is also board certified by the Saudi Internal Medicine Board.
Obaid completed a fellowship at the Royal College of Physicians in the UK in 2006.
She received certifications from the Canadian Board of Adult Neurology. Obaid then completed two fellowships. The first was in movement disorders from the University of Alberta, Canada, and the second in deep brain stimulation from the University of Joseph Fourier, France.
Obaid, who is a board member of the Saudi Alzheimer’s Disease Association and the Saudi Neurology Society, was a consultant neurologist at King Fahad Medical City (KFMC) in Riyadh. Moreover, she is also a scientific member on the neurology board at the Saudi Commission for Health Specialties. Obaid has also worked with the Dr. Sulaiman Al-Habib Medical Group.
Obaid recently participated as a speaker at the virtual Congress 2020 of the International Parkinson and Movement Disorder Society (MDS), a professional society of clinicians and healthcare professionals.